See this study presented:
Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003 (Abstract 3) (abstract and disclosures included below)
News Briefing: Monday, October 25, 9:30 a.m. Central time. Details here.
Scientific Presentation: Monday, October 25, 3:55 p.m. CT, McCormick Place West, Room W375.
ABOUT ASTRO
The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with nearly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
Back to HCB News
